Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 10;8:432. doi: 10.1038/s41392-023-01684-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — Analysis of SARS-CoV-2 genomes in the BALF samples. a Coverage distribution of reads mapped to reference SARS-CoV-2 genome, in which we found 8 complete genomes and 43 > 50% completeness. COVID-19 patients (n = 63). b Overview of SNP variant types in the assembled genome, in total we found 34 insertions, 18 deletions, and 583 substitutions. COVID-19 patients (n = 51). c Phylogenetic relationships of the 51 genomes assembled in this study vs. 682 SARS-CoV-2 genomes sampled in Beijing general population from the same period and deposited in GISAID. 20 genomes belong to BA.5 and 24 to BF.7 lineages. COVID-19 patients (n = 44). d The correlation between SARS-CoV-2 genomes of BF.7 and BA.5 lineages and 28-day mortality (survivors or non-survivors) based on Spearman’s rank test, no significant differences were found between the 28-day mortality rate in the two strains. COVID-19 patients (n = 32)